Category: Supraventricular Tachycardia (SVT)

Description

This page contains brief details about the drug adenosine, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.

Date of Approval

Adenosine was initially approved by the U.S. Food and Drug Administration (FDA) for medical use in the United States on October 30, 1989. It has been available as a prescription medication since then for the management of specific cardiac conditions, particularly supraventricular tachycardia (SVT).

Mechanism of Action of Adenosine

Adenosine has a therapeutic effect on the cardiovascular system, primarily used for the diagnosis and treatment of supraventricular tachycardia (SVT). As an antiarrhythmic agent, it works by temporarily slowing down the heart rate and interrupting abnormal electrical pathways in the heart, restoring normal sinus rhythm. This rapid action helps terminate episodes of SVT and relieves individuals experiencing rapid heart rhythms. Adenosine’s ability to restore normal heart rhythm makes it an effective tool for diagnosing and managing certain cardiac arrhythmias, contributing to the overall management of cardiovascular health.

Uses of Adenosine

Adenosine is used to diagnose and treat supraventricular tachycardia (SVT) and as a stress agent in certain cardiac imaging tests.

Adenosine Dosage available

Adenosine is administered intravenously (vein injection) under medical supervision. Your healthcare professional will determine the specific dosage and administration guidelines based on your condition and needs.